New cytokine therapeutics for inflammatory bowel disease
- 1 November 2004
- Vol. 28 (4-5) , 167-173
- https://doi.org/10.1016/j.cyto.2004.07.012
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by LipopolysaccharideThe Journal of Experimental Medicine, 2003
- Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open‐label, pilot studyAlimentary Pharmacology & Therapeutics, 2003
- Increased expression of DC‐SIGN+IL‐12+IL‐18+ and CD83+IL‐12–IL‐18– dendritic cell populations in the colonic mucosa of patients with Crohn's diseaseEuropean Journal of Immunology, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gammaGut, 2002
- Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κBJournal of Biological Chemistry, 2001
- Role of NF-κB in immune and inflammatory responses in the gutGut, 1998
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Lymphocyte Homing and HomeostasisScience, 1996
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994